Enweronu-Laryea Christabel C, Sagoe Kwamena W C, Glover-Addy Hope, Asmah Richard H, Mingle Julius A, Armah George E
Department of Child Health, University of Ghana Medical School, Accra, Ghana.
J Infect Dev Ctries. 2012 Feb 13;6(2):148-55. doi: 10.3855/jidc.1667.
Vaccination is the most effective preventive strategy against rotavirus disease. Regional differences in prevalent rotavirus genotypes may affect vaccine efficacy. Pre-vaccine surveillance for burden of rotavirus disease, prevalent rotavirus genotypes, and association between rotavirus disease and intussusceptions helps in monitoring the impact of vaccination.
A prospective study was conducted from January 2008 to December 2009 in children younger than five years hospitalized for longer than 24 hours with acute gastroenteritis. Data on confirmed cases of intussusception were collected retrospectively. Stools were tested by enzyme immunoassay, reverse-transcriptase polymerase chain reaction and nucleotide sequencing.
Acute gastroenteritis (AGE) caused 13.1% (2,147/16,348) of hospitalizations among children under five years. Stools were tested for 50.2% (1077/2147) of AGE cases. Of these, 49% (528/1077) were rotavirus positive. Rotavirus gastroenteritis, non-rotavirus gastroenteritis, and intussusceptions were most prevalent in children under 15 months [80.3%, 74% and 91% respectively]. Rotavirus was detected from more than 60% of acute gastroenteritis cases during peak months. The prevalence of intussusception showed no seasonal pattern. The peak ages of six to twelve months for acute gastroenteritis and five to eight months for intussusception overlapped. G1, G2 and mixed G/P genotypes were common in the isolated rotaviruses.
Rotavirus gastroenteritis causes significant morbidity in children younger than five years of age in Ghana. Although the peak age of rotavirus gastroenteritis and intussusceptions overlapped, there was no seasonal correlation between them. The high prevalence of mixed G/P genotypes in Ghanaian children may affect the effectiveness of vaccination.
接种疫苗是预防轮状病毒疾病最有效的策略。流行的轮状病毒基因型的区域差异可能会影响疫苗效力。疫苗接种前对轮状病毒疾病负担、流行的轮状病毒基因型以及轮状病毒疾病与肠套叠之间关联的监测,有助于监测疫苗接种的影响。
2008年1月至2009年12月,对因急性胃肠炎住院超过24小时的5岁以下儿童进行了一项前瞻性研究。回顾性收集确诊肠套叠病例的数据。粪便通过酶免疫测定、逆转录聚合酶链反应和核苷酸测序进行检测。
急性胃肠炎(AGE)导致5岁以下儿童住院病例的13.1%(2147/16348)。对50.2%(1077/2147)的AGE病例进行了粪便检测。其中,49%(528/1077)为轮状病毒阳性。轮状病毒胃肠炎、非轮状病毒胃肠炎和肠套叠在15个月以下儿童中最为常见[分别为80.3%、74%和91%]。在高峰月份,超过60%的急性胃肠炎病例检测到轮状病毒。肠套叠的患病率没有季节性模式。急性胃肠炎的高峰年龄为6至12个月,肠套叠的高峰年龄为5至8个月,两者重叠。分离出的轮状病毒中,G1、G2和混合G/P基因型较为常见。
轮状病毒胃肠炎在加纳5岁以下儿童中导致了显著的发病率。尽管轮状病毒胃肠炎和肠套叠的高峰年龄重叠,但它们之间没有季节性关联。加纳儿童中混合G/P基因型的高流行率可能会影响疫苗接种的效果。